If these are the multivariant results being presented in Nice, they don't seem much better than what we had before. Gerald said the new biomarker would significantly improve the multivariant numbers. I think we were at .86 before, this says .87. Not much improvement.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links